StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
28
This year
5
Publishing Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 25
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Sector
Health technology
28
Tags
Ak006
6
Ak007
1
Atopic dermatitis
1
Biotech-bay
1
Biotechnology
1
Business
2
Cell
4
Clinical trials
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Communications
1
Dermatitis
2
Disease
3
Ema
1
Enroll
1
Expansion
1
Financial
2
Financial results
2
Gastrointestinal
2
Growth
2
Immunology
1
Immunotherapy
1
Ipo
1
Life science
1
Market
2
Meeting
1
Money
2
N/a
20
Offering
1
Pharmaceuticals
1
Phase 2
2
Phase 2/3
2
Phase 3
2
Preclinical
3
Presentation
3
Publication
2
Report
1
Results
4
Study
1
Test
2
Topline
2
Trial
1
Trials
1
Update
2
Urticaria
4
Year
1
Entities
Allakos inc.
28
Aslan pharmaceuticals limited
1
Chinook therapeutics, inc.
1
Equillium, inc.
1
Glaxosmithkline plc
2
Intuitive surgical, inc.
1
Krystal biotech, inc.
1
Mirum pharmaceuticals, inc.
1
Novartis ag
2
Regeneron pharmaceuticals, inc.
1
Sanofi
3
Spruce biosciences, inc.
1
Teva pharmaceutical industries ltd
2
Translate bio, inc.
1
Viatris inc.
2
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
28
Nyse
2
Crawled Date
2024 - 03 - 14
1
2024 - 02 - 26
1
2024 - 02 - 12
1
2024 - 01 - 16
2
2023 - 08 - 30
1
2023 - 08 - 02
1
2023 - 06 - 12
1
2023 - 06 - 05
1
2023 - 05 - 09
1
2023 - 04 - 04
1
2022 - 11 - 29
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 19
1
2022 - 09 - 09
1
2022 - 07 - 26
1
2022 - 03 - 01
1
2021 - 12 - 22
1
2021 - 11 - 30
1
2021 - 10 - 25
1
2021 - 10 - 24
1
2021 - 06 - 07
1
2021 - 05 - 24
1
2021 - 03 - 30
1
2021 - 03 - 23
1
2021 - 03 - 01
1
2020 - 12 - 22
1
Crawled Time
00:00
1
01:00
1
09:00
1
11:00
2
12:00
5
12:20
1
13:00
2
13:03
1
15:00
1
16:00
1
17:00
1
18:00
1
19:00
1
20:00
4
20:20
1
22:00
3
23:00
1
Source
www.biospace.com
8
www.globenewswire.com
18
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
ALLK
save search
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-18.01%
|
O:
-1.15%
H:
2.33%
C:
1.55%
business
year
update
financial
results
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
Published:
2024-02-26
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-21.32%
|
O:
2.21%
H:
10.07%
C:
5.04%
ak006
cell
preclinical
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
Published:
2024-02-12
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-20.15%
|
O:
1.49%
H:
10.29%
C:
2.21%
ak006
publication
cell
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.21%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
urticaria
dermatitis
trials
Allakos Announces a Restructuring to Focus on Development of AK006
Published:
2024-01-16
(Crawled : 12:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-64.21%
|
O:
-59.2%
H:
10.66%
C:
-2.46%
ak006
Allakos Appoints Neil Graham to its Board of Directors
Published:
2023-08-30
(Crawled : 20:00)
- globenewswire.com
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
7.41%
|
O:
0.11%
H:
0.0%
C:
-1.12%
ASLN
|
News
|
$0.54
0.0%
26K
|
Health Technology
|
-75.71%
|
O:
1.9%
H:
0.93%
C:
-0.7%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-63.48%
|
O:
1.02%
H:
5.17%
C:
-2.7%
Allakos Appoints Rand Sutherland and Dolca Thomas to its Board of Directors
Published:
2023-08-02
(Crawled : 20:00)
- globenewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.05%
|
O:
-1.6%
H:
0.11%
C:
0.11%
TBIO
|
$0.302
-8.76%
-9.6%
160K
|
Health Technology
|
-78.62%
|
O:
-0.69%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.21%
|
O:
-3.79%
H:
0.0%
C:
0.0%
KRYS
|
$158.63
-3.26%
-3.37%
340K
|
Health Technology
|
22.89%
|
O:
-2.31%
H:
0.73%
C:
-1.14%
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
114.67%
|
O:
9.59%
H:
7.68%
C:
-6.75%
KDNY
|
$40.39
0.22%
-0.17%
0
|
Health Technology
|
0.5%
|
O:
0.02%
H:
0.26%
C:
0.22%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.51%
|
O:
-0.91%
H:
1.84%
C:
-1.1%
Allakos Presents Preclinical Data at EAACI Hybrid Congress 2023 Highlighting Lirentelimab and AK006 Mechanisms of Mast Cell Inhibition
Published:
2023-06-12
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-77.71%
|
O:
0.0%
H:
5.21%
C:
2.71%
ak006
cell
preclinical
Allakos Announces Upcoming Presentation on Lirentelimab and AK006 Mast Cell Inhibition at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023
Published:
2023-06-05
(Crawled : 11:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-79.62%
|
O:
0.0%
H:
0.95%
C:
-2.29%
ak006
presentation
cell
immunology
Allakos Provides Business Update and Reports First Quarter 2023 Financial Results
Published:
2023-05-09
(Crawled : 20:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-75.17%
|
O:
0.46%
H:
5.54%
C:
-0.92%
business
update
financial
results
Urticaria Drugs Market size to grow by USD 1.31 billion from 2021 to 2026, Driven by the growth in incidence of urticaria - Technavio
Published:
2023-04-04
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
12.79%
|
O:
1.79%
H:
3.07%
C:
3.07%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-15.15%
|
O:
0.69%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
21.22%
|
O:
1.57%
H:
1.01%
C:
0.96%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
18.05%
|
O:
-0.1%
H:
3.15%
C:
2.94%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.94%
|
O:
1.29%
H:
0.83%
C:
0.4%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
8.76%
|
O:
1.2%
H:
1.32%
C:
1.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.82%
|
O:
1.58%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-74.4%
|
O:
-0.96%
H:
1.21%
C:
-0.24%
urticaria
growth
market
Allakos Announces Publication of AK006 Mechanism of Action Manuscript in Communications Biology
Published:
2022-11-29
(Crawled : 12:20)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-85.46%
|
O:
0.54%
H:
9.19%
C:
7.3%
ak006
communications
publication
Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer’s 37th Annual Meeting
Published:
2022-11-10
(Crawled : 16:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-83.93%
|
O:
3.6%
H:
2.17%
C:
2.17%
ak007
preclinical
immunotherapy
meeting
USD 1.31 Bn growth for Urticaria Drugs Market through 2026: Analysing growth for Pharmaceuticals - Technavio
Published:
2022-09-29
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
33.95%
|
O:
-3.32%
H:
4.73%
C:
4.73%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
22.25%
|
O:
0.22%
H:
0.33%
C:
0.33%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
51.07%
|
O:
1.87%
H:
0.0%
C:
0.0%
VTRS
A
|
$11.25
1.17%
1.16%
4.7M
|
Health Technology
|
28.87%
|
O:
-1.26%
H:
0.7%
C:
-0.23%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
23.64%
|
O:
0.17%
H:
1.1%
C:
0.16%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
34.93%
|
O:
-0.14%
H:
0.53%
C:
-0.2%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
22.52%
|
O:
-0.13%
H:
0.0%
C:
0.0%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-81.46%
|
O:
-2.77%
H:
2.14%
C:
-0.18%
pharmaceuticals
urticaria
growth
market
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
Published:
2022-09-19
(Crawled : 13:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-76.64%
|
O:
16.59%
H:
14.79%
C:
9.36%
offering
Allakos Announces Topline Phase 3 Data from the EoDyssey Study in Patients with Eosinophilic Duodenitis
Published:
2022-09-09
(Crawled : 22:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-76.94%
|
O:
-8.41%
H:
18.12%
C:
15.41%
topline
study
Allakos Announces the Appointment of Dr. Amy Ladd to its Board of Directors
Published:
2022-07-25
(Crawled : 00:00)
- biospace.com/
ISRG
|
$366.1
-1.75%
-1.78%
3.8M
|
Health Technology
|
72.92%
|
O:
0.64%
H:
4.03%
C:
2.8%
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-72.28%
|
O:
-0.26%
H:
0.71%
C:
-4.42%
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-03-01
(Crawled : 23:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-80.33%
|
O:
-2.02%
H:
7.5%
C:
4.5%
financial results
report
results
Allakos Announces Topline Phase 3 Data from the ENIGMA 2 Study and Phase 2/3 Data from the KRYPTOS Study in Patients with Eosinophilic Gastrointestinal Diseases
Published:
2021-12-22
(Crawled : 01:00)
- globenewswire.com
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.73%
|
O:
-87.46%
H:
2.55%
C:
-19.19%
phase 2
phase 2/3
gastrointestinal
disease
test
topline
phase 3
Allakos Announces Expansion of Lirentelimab Development into Atopic Dermatitis, Chronic Spontaneous Urticaria and Asthma
Published:
2021-11-30
(Crawled : 15:00)
- biospace.com/
ALLK
|
$1.065
0.47%
0.47%
420K
|
Health Technology
|
-98.65%
|
O:
-0.92%
H:
0.0%
C:
0.0%
atopic dermatitis
expansion
dermatitis
urticaria
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.